Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis.
Busque
S
S
Department of Surgery, Centre Hospitalier de l'Université de Montréal, Canada.
Demers
P
P
St-Louis
G
G
Boily
J G
JG
Tousignant
J
J
Lemieux
F
F
Smeesters
C
C
Corman
J
J
Daloze
P
P
D000328:Adult; D000368:Aged; D002784:Cholesterol / Q000097:blood; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects*; D005885:Gingival Hyperplasia / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D006983:Hypertrichosis / Q000139:chemically induced* / Q000517:prevention & control; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D016559:Tacrolimus / Q000097:blood / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D007166:Immunosuppressive Agents; D014280:Triglycerides; D016572:Cyclosporine; D002784:Cholesterol; D003404:Creatinine; D011241:Prednisone; D016559:Tacrolimus